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Abstract
Background: Whenever technically feasible and oncologically justified, nephron-sparing surgery is the current
standard of care for localized renal cell carcinomas (RCC). The main complications of partial nephrectomy,
especially for large and centrally located tumors, are urinary leakage and parenchymal bleeding. We prospectively
evaluated the pros and cons of using porcine small intestinal submucosa (SIS, Surgisis
®) to close the renal defect
after nephron-sparing surgery.
Methods: We used Surgisis
® (Cook medical, Bloomington, IN, USA) to secure and compress the capsular defect after
tumor resection in 123 patients submitted to 129 partial nephrectomies between August 2003 and February 2011.
Results: The median tumor size was 3.7 cm (range 1.1-13.0 cm). Procedures were performed with cold ischemia in
24 cases (18.2%), with warm ischemia in 46 (35.6%), and without ischemia in 59 cases (44.8%). In the total group of
patients, 4 (3.1%) developed urinary fistula, and only 2 (1.6%) required postoperative transfusions due to
hemorrhage after the application of the small intestinal submucosa membrane.
Conclusion: Small intestinal submucosa is an easy-to-use biomaterial for preventing complications such as
postoperative bleeding and urinary fistula in nephron-sparing surgery, especially in cases where tumor excision
causes significant renal capsular and/or renal pelvic defects.
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Background
Whenever technically feasible and oncologically justified,
nephron-sparing surgery is the current standard of care
for localized renal tumors of any size [1]. Its high status
is based on substantial evidence from numerous studies
confirming that postoperative morbidity such as cardio-
vascular disease, diabetes and renal failure can thus be
avoided without significantly increasing the risk of tumor
recurrence [2-5]. Nevertheless, the proportion of
nephron-sparing interventions in most urological centers
is still well below 50% [6]. One reason for this discre-
pancy may be that partial nephrectomy is sometimes
technically demanding and occasionally involves signifi-
cant complications in a percentage of patients that merits
attention. The most prevalent adverse outcomes after
partial nephrectomy include urinary leakage/fistula (1.3 -
9.1%) and parenchymal bleeding (0 - 7.9%) with higher
complication rates after excision of larger tumors [7-15].
Porcine small intestinal submucosa (SIS, Surgisis
®)i sa
natural acellular collagen-based biomaterial. The Surgi-
sis
® membrane is increasingly used for different pur-
poses in abdominal surgery [16,17], gynecology and
obstetrics [18], and, more recently, urology [19-21].
We describe the use of this small intestinal submucosa
membrane to optimize and facilitate closure of the col-
lecting system and particularly the parenchymal defect
and to minimize parenchymal bleeding after partial
nephrectomy in a series of 123 patients.
Materials and methods
Surgisis
® (Cook medical, Bloomington, IN, USA) was
used to close and secure the capsular defect in 123
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August 2003 to March 2011 (Figure 1).
After excising the tumor with a normal tissue margin
using a Leriche dissector for blunt dissection as
described earlier [20], we ligated or clipped visible blood
vessels within the renal defect. The collecting system, if
necessary, was closed with monofilament sutures. A pye-
lostoma or mono-J catheter was inserted in cases with
large collecting system defects. The renal defect was
then treated with a hemostyptic agent such as TachoSil
®
(Nycomed, Unterscheissheim, Germany), FloSeal
® (Bax-
ter, Deerfield, IL, USA), and/or Tabotamp
® (Johnson &
Johnson Medical GmbH, Norderstedt, Germany). The
hydrated Surgisis
® membrane was then cut into shape
and tightly fixed over the parenchymal defect with a 3-0
Vicryl a running suture mimicking the fixation of a
drumhead (Figure 2). Suturing of the renal surface was
kept superficial, since deep stitches cause additional par-
enchymal scarring. If FloSeal
® was used for hemostasis,
it was injected into the parenchymal defect beneath the
Surgisis
® tissue graft just before finishing the running
sutures securing the membrane. A percutaneous drain
was placed to monitor postoperative bleeding and urin-
ary leakage.
Results
Depending on the tumor size and/or location within the
kidney, procedures were performed with cold ischemia
in 24/129 cases (18.6%), with warm ischemia in 46/129
(35.6%), and without ischemia in 59/129 (45.8%) cases.
The median tumor size was 3.7 cm (range 1.1-13.0 cm).
Thirty-one lesions were benign, and 98 were classified
as RCC. In the latter group, staging revealed 94 pT1
tumors, 1 pT2 tumor, 2 pT3 tumors, and 1 pT4 tumor.
It generally took about 5-10 min to fix the Surgisis
®
membrane over the renal defect.
Four patients (3.1%) developed postoperative urinary
fistulas, three of whom had tumors > 4 cm. However,
the insertion of Mono-J and/or Double-J catheters
achieved fistula closure without further intervention.
Two patients (1.6%) with significant postoperative bleed-
ing required reoperation or coiling of a segmental artery.
The reason for reoperation was a bleeding venotomy
suture line following in situ cold perfusion immediately
after the primary surgical procedure.
Figures 3 and 4 show pictures of a patient with
chronic renal failure who suffered from a large renal cell
carcinoma and was treated by partial nephrectomy. The
renal defect was easily closed and controlled using a
Surgisis
® membrane.
Discussion
The incidence of localized renal cell carcinoma (RCC)
continues to increase; these tumors account for up to
81% of all RCC at diagnosis, at least in urban areas [6].
Nephron-sparing surgery is now the recommended
Figure 1 Schematic illustration of a partial nephrectomy and subsequent application of Surgisis
® to optimize and facilitate the closure
of the renal defect: A) Tumor in place, B) kidney after tumor excision, C) creation of a phantom or placeholder volume using a hemostyptic
agent, D) optimum hemostasis after fixation of Surgisis
® to apply homogeneous pressure onto the resection ground.
Figure 2 Schematic illustration of the running suture technique
mimicking the fixation of a drumhead to fix the Surgisis
®
membrane to the renal capsule over the renal defect.
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[1,22,23], although this is not yet reflected in routine
clinical practice. A recently published population-based
case-control study conducted by Miller et al. [6] in
metropolitan Detroit and Chicago showed that until
2007 almost 80% of patients with localized RCC were
treated by radical and only 20% by partial nephrectomy.
This is alarming, since several trials have clearly demon-
strated that total removal of the kidney was associated
with a higher risk of postoperative renal failure [2], car-
diovascular disease [3], diabetes [4] and even early death
[3,5].
While it is generally agreed that a nephron-sparing
approach should be adopted for surgical treatment of
localized RCC, the optimal technique (open, laparo-
scopic, or robot-assisted) is still under debate and prob-
ably of secondary importance [10,24,25].
Despite the steadily decreasing incidence of postopera-
tive adverse events after partial nephrectomy, mostly
due to the development of novel hemostyptic agents, a
significant number of complications still occur. In a
2007 study on partial nephrectomy in 1,800 patients
(median tumor size 3 cm), Gill et al. [10] reported that
5-9% had postoperative urological complications, includ-
ing hemorrhage (2-4%), urine leakage (2-3%), and renal
failure (1-2%). Subsequent invasive procedures were
required in 4-7% of all patients. Moreover, the compli-
cation rate seems to increase with the size of the defect
after tumor excision [7].
Here we describe an improved technique for parench-
ymal defect closure in which the use of a modern
hemostyptic agent is combined with Surgisis
® mem-
brane placement to secure and compress the defect
without causing significant additional renal parenchymal
injury or scarring. In contrast to conventional surgical
techniques for hemostasis, the use of a Surgisis
® mem-
brane does not compromise blood flow in the parenchy-
mal resection margin, since no parenchymal tissue has
to be gathered or folded. The running suture technique
mimicking the fixation of a drumhead (Figure 2) addi-
tionally enables maximal stability and prevents tearing
of the suture from the renal capsule [26]. Another great
advantage of this technique is the establishment of a
phantom or placeholder volume beneath the membrane
(Figure 1) which enables the establishment of homoge-
nous pressure on the resection area. After > 120 appli-
cation, we feel that this can most easily be achieved
using Flowseal because of its swell volume of approxi-
mately 20% [27], which is achieved within only a few
minutes and leads to an additi o n a lp h y s i c a lr e s t r i c t i o n
of blood flow.
Significant postoperative bleeding from the tumor base
occurred in 0.8% and urinary fistulas in 3.1% of our
patient population, only. Thus the procedure described
here may further reduce the complication rate of partial
nephrectomy and helps to minimize the loss of func-
tional renal tissue. We also feel that the use of this sim-
plified and safe surgical technique could further increase
the proportion of patients undergoing nephron-sparing
surgery, which has surely become one of the most
important goals in the treatment of localized RCC.
Also noteworthy in this context is a recent study by
O’Connor et al. [21] who reported that one of their 24
patients submitted to partial nephrectomy using a Surgi-
sis
® membrane had to undergo a second partial
nephrectomy for a new ipsilateral tumor 9 months after
the original procedure. Intraoperatively, the reoperated
kidney appeared absolutely normal with total incorpora-
tion of Surgisis
® into the collecting system and parench-
yma. As in animal models, this membrane appeared to
have been replaced by native tissue with no significant
Figure 3 Large clear cell renal cell carcinoma prior to nephron-
sparing surgery in a patient with chronic renal failure.
Figure 4 Hydrated porcine small intestinal submucosa
(Surgisis
®) trimmed and tacked in place over the large renal
parenchymal defect (cf. Figure 3), fixed with two running
sutures.
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in cases of angiomyolipoma or familial renal tumors
that may require multiple, ipsilateral partial nephrec-
tomies [21].
A disadvantage of the surgical technique described
here is the expense involved; we pay approximately €
204 for one Surgisis
® membrane. In addition, the suit-
ability of this technique for endoscopic tumor enuclea-
tions still has to be assessed.
Conclusion
Surgisis
® membrane placement combined with the use
of a conventional hemostyptic agent is effective, free
from side effects, and very easy to perform; it is indi-
cated especially for safe closure of large renal capsular
defects. Therefore, currently a clinical trial is being
planned in cooperation with the German Renal Cell
Cancer Network, in which the application of Surgisis
®
will be evaluated vs. standard closure of renal defects for
tumors with a diameter > 4 cm. We do hope that the
establishment of novel techniques such as the applica-
tion of Surgisis
® will further increase the proportion of
patients undergoing nephron-sparing surgery.
Author details
1Department of Urology, Ulm University Medical Center, Prittwitzstrasse 43,
D-89075 Ulm, Germany.
2Department of Urology, Hannover Medical School,
Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.
Authors’ contributions
TJM provided the idea, collected the data, and contributed by writing parts
of the manuscript; RP performed most operations and supplied Figures 1+2;
RH and FJ performed several partial nephrectomies using surgisis
®® and
helped to discuss the data; SW, FZ, and MS contributed mainly in designing,
literature review, and writing of the manuscript; AJS, the corresponding
author of this study, planed, corrected, and approved the written work, and
supplied Figures 3+4. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 25 May 2011 Accepted: 12 October 2011
Published: 12 October 2011
Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA,
Merseburger AS, Patard JJ, Mulders PF, Sinescu IC: EAU guidelines on
renal cell carcinoma: the 2010 update. Eur Urol 2010, 58:398-406.
2. Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A,
Marechal JM, Klotz L, Skinner E, Keane T, et al: A prospective randomized
EORTC intergroup phase 3 study comparing the complications of
elective nephron-sparing surgery and radical nephrectomy for low-stage
renal cell carcinoma. Eur Urol 2007, 51:1606-1615.
3. Lughezzani G, Jeldres C, Budaus L, Shariat SF, Liberman D, Thuret R,
Widmer H, Arjane P, Patard JJ, Perrotte P, et al: The effect of radical versus
partial nephrectomy on other-cause mortality in patients with T1a renal
cell carcinoma: results from the surveillance, epidemiology and end
results database. J Urol 2010, 183, AUA abstract 826.
4. Derweesh I, Jolla L, Mehrazin R, Bazzi W, Kopp R, Silberstein J, Belderian S,
Shiau J, Chenoweth M, Downs T, et al: Variations in incidence of and risk
factors for development of diabetes mellitus after radical or partial
nephrectomy. J Urol 2010, 183, AUA abstract 814.
5. Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC,
Blute ML: Radical nephrectomy for pT1a renal masses may be associated
with decreased overall survival compared with partial nephrectomy. J
Urol 2008, 179:468-471, discussion 472-463.
6. Miller DC, Ruterbusch J, Colt JS, Davis FG, Linehan WM, Chow WH,
Schwartz K: Contemporary clinical epidemiology of renal cell carcinoma:
insight from a population based case-control study. J Urol 184:2254-2258.
7. Uzzo RG, Novick AC: Nephron sparing surgery for renal tumors:
indications, techniques and outcomes. J Urol 2001, 166:6-18.
8. Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT,
Zincke H: Disease outcome in patients with low stage renal cell
carcinoma treated with nephron sparing or radical surgery. J Urol 1996,
155:1868-1873.
9. Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG: Oncological
efficacy and safety of nephron-sparing surgery for selected patients with
locally advanced renal cell carcinoma. BJU Int 2007, 100:1235-1239.
10. Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I,
Permpongkosol S, Weight CJ, Kaouk JH, et al: Comparison of 1,800
laparoscopic and open partial nephrectomies for single renal tumors. J
Urol 2007, 178:41-46.
11. Duque JL, Loughlin KR, O’Leary MP, Kumar S, Richie JP: Partial
nephrectomy: alternative treatment for selected patients with renal cell
carcinoma. Urology 1998, 52:584-590.
12. Schiff JD, Palese M, Vaughan ED Jr, Sosa RE, Coll D, Del Pizzo JJ:
Laparoscopic vs open partial nephrectomy in consecutive patients: the
Cornell experience. BJU Int 2005, 96:811-814.
13. Becker F, Siemer S, Hack M, Humke U, Ziegler M, Stockle M: Excellent long-
term cancer control with elective nephron-sparing surgery for selected
renal cell carcinomas measuring more than 4 cm. Eur Urol 2006,
49:1058-1063, discussion 1063-1054.
14. Belldegrun A, Tsui KH, deKernion JB, Smith RB: Efficacy of nephron-sparing
surgery for renal cell carcinoma: analysis based on the new 1997 tumor-
node-metastasis staging system. J Clin Oncol 1999, 17:2868-2875.
15. Van Poppel H, Bamelis B, Oyen R, Baert L: Partial nephrectomy for renal
cell carcinoma can achieve long-term tumor control. J Urol 1998,
160:674-678.
16. Clough A, Ball J, Smith GS, Leibman S: Porcine small intestine submucosa
matrix (Surgisis) for esophageal perforation. Ann Thorac Surg 2011, 91:
e15-16.
17. Lupinacci RM, Vallet C, Parc Y, Chafai N, Tiret E: Treatment of fistula-in-ano
with the Surgisis((R)) AFP(TM) anal fistula plug. Gastroenterol Clin Biol
2011, 34:549-553.
18. Khong SY, Lam A: Use of Surgisis mesh in the management of
polypropylene mesh erosion into the vagina. Int Urogynecol J Pelvic Floor
Dysfunct 2011, 22:41-46.
19. Ecke TH, Hallmann S, Gerullis H, Ruttloff J: Reconstruction of the urethra
with a Surgisis onlay patch in urethral reconstructive surgery: two case
reports. J Med Case Reports 2009, 3:7232.
20. Simon J, de Petriconi R, Meilinger M, Hautmann RE, Bartsch G Jr: Optimized
haemostasis in nephron-sparing surgery using small-intestine
submucosa. BMC Urol 2008, 8:8.
21. O’Connor RC, Harding JN, Steinberg GD: Novel modification of partial
nephrectomy technique using porcine small intestine submucosa.
Urology 2002, 60:906-909.
22. Gupta G, Peterson J, Daryanani D, Pinto P, Linehan WM, Bratslavsky G:
Oncologic outcomes of partial nephrectomy for multifocal renal cell
carcinoma with largest tumor greater then 4 cm. J Urol 2010, 183, AUA
abstract 986.
23. Weight C, Lieser G, Larson B, Lygothe C, Lane B, Campbell S, Kaouk J, Gill I,
Fergany A: Pathological upstaging does not affect survival in patients
with pT2/T3 renal tumors treated by either partial nephrectomy or
radical nephrectomy. J Urol 2010, 183, AUA abstract 1241.
24. Simhan J, Uzzo R, Chen D, Boorjian S, Scoll B, Viterbo R: Open,
laparoscopic, and robotic partial nephrectomy: a single institution
analysis with perioperative and oncologic outcomes. J Urol 2010, 183,
AUA abstract 988.
25. Lane B, Weight C, Campbell S: Renal functional outcomes after partial
nephrectomy with extended ischemic intervals are better than after
radical nephrectomy. J Urol 2010, 183, AUA abstract 815.
Schnoeller et al. World Journal of Surgical Oncology 2011, 9:126
http://www.wjso.com/content/9/1/126
Page 4 of 526. Simon J, Finter F, Ignatius A, Meilinger M, Durselen L: Maximum tensile
force of different suture techniques in reconstruction of the renal
remnant after nephron-sparing surgery. Surg Endosc 2011, 25:503-507.
27. Oz MC, Cosgrove DM, Badduke BR, Hill JD, Flannery MR, Palumbo R,
Topic N: Controlled clinical trial of a novel hemostatic agent in cardiac
surgery. The Fusion Matrix Study Group. Ann Thorac Surg 2000,
69:1376-1382.
28. Badylak SF: Small intestine submucosa (SIS): a biomateral conducive to
smart tissue remodeling. In Tissue Engineering: Current Perspectives. Edited
by: E B. Cambridge, Massachusetts: Burkhauser Publishers; 1993:179-189.
doi:10.1186/1477-7819-9-126
Cite this article as: Schnoeller et al.: Partial nephrectomy using porcine
small intestinal submucosa. World Journal of Surgical Oncology 2011 9:126.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Schnoeller et al. World Journal of Surgical Oncology 2011, 9:126
http://www.wjso.com/content/9/1/126
Page 5 of 5